Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 1631-1640 Newer>

The Motley Fool April 19, 2004 Nathan Slaughter	GTech Is a Money Maker Lottery operator GTech reports record revenues and raises its guidance.
The Motley Fool April 19, 2004 Alyce Lomax	Mickey D's Unhappy Day McDonald's loses its star chairman and CEO, Jim Cantalupo, to a heart attack.
The Motley Fool April 19, 2004 Seth Jayson	Lexmark Inks More Profits The printer maker lives up to its buzz and continues to increase earnings.
The Motley Fool April 19, 2004 W.D. Crotty	3M: Money, Margins, Magnificent Trusty old 3M is no ordinary industrial conglomerate.
The Motley Fool April 19, 2004 Rich Smith	Superior Industries' Inferior Result There is good reason for the auto parts maker's low valuation.
The Motley Fool April 19, 2004 Alyce Lomax	Eli Lilly's Drug Dependency Competitive concerns make Cymbalta and new drugs more important than ever.
The Motley Fool April 19, 2004 Dave Marino-Nachison	VCampus' Security Blanket New course offerings in computer and network security woke up the online educator's shares.
The Motley Fool April 19, 2004 Ben McClure	Ruminations on R&D Spending on research and development is important. But can it help identify promising investments? It's pretty easy to spot companies that spend a lot of money on R&D. It's another thing to pick companies that translate R&D spending into higher stock prices.
The Motley Fool April 19, 2004 Charly Travers	4 Promising Biotech IPOs Several recently gone-public biotechs boast surprisingly interesting drug pipelines. From drugs for hepatitis to hopeful cancer treatments, watch out for these four biotech debutantes. If trials go smoothly, they may be the next up-and-coming stocks in the industry.
The Motley Fool April 19, 2004 Seth Jayson	Hasbro Has-Been? Earnings are up, but do soggy sales raise a red flag?
<Older 1631-1640 Newer> Return to current articles.